Home > Healthcare > Pharmaceuticals > Finished Drug Form > Pain Relief Patches Market

Pain Relief Patches Market Share

Report ID: GMI10077
Published Date: Jul 2024
Report Format: PDF

Download Free Sample

Pain Relief Patches Market Share

Pain relief patches industry seem to be consolidated in nature due to presence of local and global players across the globe. In 2023, the market players such as Hisamitsu Pharmaceutical Co., Inc., Mylan N.V., GlaxoSmithKline plc, Johnson & Johnson, Sanofi, Novartis AG, Pfizer Inc. and Teva Pharmaceutical Industries Ltd. collectively held around 10%-15% market share. These prominent players are proactively involved in strategic endeavors, such as mergers & acquisitions, facility expansions & collaborations, to expand their product portfolios, extend their reach to a broader customer base, and strengthen their market position.

Pain Relief Patches Market Companies

Major players operating in the pain relief patches industry are:

3M Health Care
Actavis
BioElectronics Corporation
Chattem, Inc.
Endo International plc
GlaxoSmithKline plc
Hisamitsu Pharmaceutical Co., Inc.
Johnson & Johnson
Mylan N.V.
Novartis AG
Pfizer Inc.
Reckitt Benckiser Group plc
Salonpas
Sanofi
Teva Pharmaceutical Industries Ltd.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market size of pain relief patches reached USD 3.9 billion in 2023 and will witness 6.2% CAGR between 2024 and 2032, propelled by the rising prevalence of chronic pain conditions, including arthritis and back pain, and increasing awareness of non-invasive pain management solutions.

The muscle pain application segment achieved 41% of the pain relief patches industry share in 2023 due to the widespread prevalence of muscle pain from physical activity, sports injuries, and aging.

North America market will record USD 1.8 billion by 2032, owing to the advanced technological capabilities and significant investment in R&D, high prevalence of chronic pain conditions and the strong healthcare infrastructure.

Some of the leading industry players include 3M Health Care, Actavis, Chattem, Inc., Endo International plc, GlaxoSmithKline plc, Hisamitsu Pharmaceutical Co., Inc., Johnson & Johnson, Mylan N.V., Novartis AG, Pfizer Inc., Reckitt Benckiser Group plc, Salonpas, Sanofi, and Teva Pharmaceutical Industries Ltd. among others.